Literature DB >> 10853990

Pharmacokinetics of indinavir in HIV-positive pregnant women.

S Hayashi, K Beckerman, M Homma, B W Kosel, F T Aweeka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853990     DOI: 10.1097/00002030-200005260-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women.

Authors:  Déborah Hirt; Jean-Marc Treluyer; Vincent Jullien; Ghislaine Firtion; Hélène Chappuy; Elisabeth Rey; Gérard Pons; Laurent Mandelbrot; Saïk Urien
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Implications of gender and pregnancy for antiretroviral drug dosing.

Authors:  Brookie M Best; Edmund V Capparelli
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

4.  Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.

Authors:  P Villani; M Floridia; M F Pirillo; M Cusato; E Tamburrini; A F Cavaliere; G Guaraldi; C Vanzini; A Molinari; A degli Antoni; M Regazzi
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 5.  Pharmacokinetics of antiretrovirals in pregnant women.

Authors:  Mark Mirochnick; Edmund Capparelli
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 6.  Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Authors:  Matthieu Roustit; Malik Jlaiel; Pascale Leclercq; Françoise Stanke-Labesque
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

7.  Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.

Authors:  Jade Ghosn; Ines De Montgolfier; Chantal Cornélie; Stéphanie Dominguez; Claire Pérot; Gilles Peytavin; Anne-Geneviève Marcelin; Michèle Pauchard; Zineb Ouagari; Manuela Bonmarchand; Rachid Agher; Vincent Calvez; François Bricaire; Marc Dommergues; Christine Katlama; Roland Tubiana
Journal:  Antimicrob Agents Chemother       Date:  2008-02-04       Impact factor: 5.191

Review 8.  Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Authors:  Kajal Buckoreelall; Tim R Cressey; Jennifer R King
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 5.577

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.